As girls grow into women and are faced with choices of contraceptives a valuable resource is the U.S. Food and Drug Administration.
The FDA offers a warning about the dangerous side effects of some of the most popular birth control pills that contain drospirenone, such as top-sellers Yaz and Yasmin.
Here’s the language from an FDA 2011 National Drug Safety Communication:
- Women should talk to their healthcare professional about their risk for blood clots before deciding which birth control method to use.
- Healthcare professionals should consider the risks and benefits of drospirenone-containing birth control pills and a woman’s risk for developing a blood clot before prescribing these drugs.
The FDA has conducted an extensive review of dangerous side effects linked to Yaz, Yasmin and other drospirenone-containing birth control pills and concluded in a National Drug Safety Communication that the contraceptives put women at “higher risk” of suffering a potentially fatal blood clot than other birth control pills.
The villain, as identified by the FDA, is drospirenone, a synthetic version of the female hormone, progesterone, also referred to as a progestin.
If you are considering Yaz or Yasmin as your choice of contraception you should also be aware that there have been thousands and thousands of Yaz and Yasmin blood-clotting lawsuits filed in state and federal courts across the country.
The court files shows that the women are making common allegations that that Yaz and Yasmin (drospirenone) caused them to develop potentially fatal blood-clotting problems and they are seeking compensation for medical costs and other expenses.
Bayer, the German pharmaceutical giant that manufactures Yaz and Yasmin, has reported to shareholders in financial statements that it has so far paid out over $1.6 billion to settle Yaz and Yasmin blood-clot lawsuits.